The future of clinical trial data sharing [Video]
The following video on clinical trial data sharing was presented at the DIA 2015 51st Annual Meeting.
Presentations now available from the 4th World Conference on Research Integrity
The 4th World Conference on Research Integrity recently took place in Rio de Janeiro (from 31 May-3 June). The main theme for the conference was “How to improve the research … Continue Reading Presentations now available from the 4th World Conference on Research Integrity
Presentations available from the meeting: “An Update: Publications in Practice”
Some of the educational presentations are now available to download from the recent “An Update: Publications in Practice” meeting. These presentations cover subjects such as the impact of the Sunshine … Continue Reading Presentations available from the meeting: “An Update: Publications in Practice”
Terminated trials in the ClinicalTrials.gov results database: reasons for termination and availability of results
A study published in PLOS ONE last week attempted to characterise the reasons why trials (listed on http://www.clinicaltrials.gov) were terminated, and also examined the availability of results from these trials. … Continue Reading Terminated trials in the ClinicalTrials.gov results database: reasons for termination and availability of results
The International Society for Medical Publication Professionals (ISMPP): a decade of achievements
This year marks the 10th anniversary of the formation of the International Society for Medical Publication Professionals (ISMPP). To mark this occasion, ISMPP have developed a presentation that provides an … Continue Reading The International Society for Medical Publication Professionals (ISMPP): a decade of achievements
What is the impact of open data policies on participation in clinical trials?
There are obvious benefits associated with open data policies for the scientific community. As a consequence, research organisations are increasingly adopting open data policies as a requisite for publication. However, … Continue Reading What is the impact of open data policies on participation in clinical trials?
GSK’s road to clinical trial transparency
GSK’s road to increasing clinical trial transparency is laid out in a document released by EFPIA today. This “road map” can be found here. Researchers can submit proposals and request … Continue Reading GSK’s road to clinical trial transparency
Videos now available from Evidence Live 2015
The videos are now available on YouTube from the recent Evidence Live 2015 meeting in Oxford. Presentations available include: Iona Heath – Eminence or evidence-based medicine: why this question is … Continue Reading Videos now available from Evidence Live 2015
Contract research organisation using court action to challenge data transparency
The UK Health Research Authority is facing a legal review over its work to advance clinical trial transparency, the Guardian reported this week. The legal review was launched by Richmond … Continue Reading Contract research organisation using court action to challenge data transparency
Understanding industry bias and potential conflicts of interest
An Editorial in this week’s New England Journal of Medicine provides a thoughtful overview of the relationship between physicians and industry, and warns of the dangers of bias against industry-sponsored … Continue Reading Understanding industry bias and potential conflicts of interest
The BMJ have extended their policy relating to sharing clinical trial data (@bmj_latest)
Heeding calls from the Institute of Medicine, WHO, and the Nordic Trial Alliance, The BMJ are extending their policy on requiring the sharing of individual patient data for trials of … Continue Reading The BMJ have extended their policy relating to sharing clinical trial data (@bmj_latest)
Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN project
The aims of the OPEN project (http://www.open-project.eu) are to assess the current evidence on publication bias and to describe current practices by various key groups involved in funding, conducting and … Continue Reading Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN project
New study suggests that transparency amongst industry-sponsored clinical trials is improving
A study from the Association of the British Pharmaceutical Industry (ABPI) published this week in the peer-review journal Current Medical Research and Opinion (CMRO) suggests that transparency amongst industry-sponsored clinical … Continue Reading New study suggests that transparency amongst industry-sponsored clinical trials is improving
Revised guidelines relating to the development of medical publications to be published in the near future (GPP-3)
Most people involved in the development of medical publications – and particularly those from industry – are familiar with the Good Publication Practice (GPP)-2 guidelines, which were published in 2009. … Continue Reading Revised guidelines relating to the development of medical publications to be published in the near future (GPP-3)
Nordic researchers want to lead the world in clinical trial transparency
A new report, written by Nordic clinical trial experts, sets a high international standard for clinical trial transparency and sets out how to make it a reality. The report from … Continue Reading Nordic researchers want to lead the world in clinical trial transparency
Free educational meeting on medical publications in Cheshire, UK on 3rd June
An educational afternoon meeting will be held at Alderley Park in Cheshire on the 3rd of June, entitled: “An update: Publications in Practice”. The programme for this meeting is now … Continue Reading Free educational meeting on medical publications in Cheshire, UK on 3rd June